Spatial localization of the JAG1/Notch1/osteopontin cascade modulates extrahepatic metastasis in hepatocellular carcinoma

International Journal of Oncology

Volumn 45, Issue 5, 2014, Pages 1883-1890

  Xue, Tong Chun ^a   Zou, Jing Huai ^a   Chen, Rong Xin ^a   Cui, Jie Feng ^a   Tang, Zhao You ^a   Ye, Sheng Long ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Jagged1; Metastasis; Notch1; Osteopontin

Indexed keywords

JAGGED1; NOTCH1 RECEPTOR; OSTEOPONTIN; SMALL INTERFERING RNA; CALCIUM BINDING PROTEIN; MEMBRANE PROTEIN; NOTCH1 PROTEIN, HUMAN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOPLASM; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EXTRAHEPATIC METASTASIS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CANCER CELL LINE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY; AGED; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

AGED; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM METASTASIS; OSTEOPONTIN; PROGNOSIS; RECEPTOR, NOTCH1; SIGNAL TRANSDUCTION;

EID: 84907218334     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2630     Document Type: Article

References (28)

1. Ranganathan P, Weaver KL and Capobianco AJ: Notch signalling in solid tumours: A little bit of everything but not all the time. Nat Rev Cancer 11: 338-351, 2011.
2. Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and Dou KF: The down-regulation of Notch1 inhibits the invasion and migration of hepatocellular carcinoma cells by inactivating the cyclooxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci 58: 1016-1025, 2013.
3. Lim SO, Park YM, Kim HS, et al: Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology 53: 1352-1362, 2011.
4. Liu M, Lee DF, Chen CT, et al: IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression. Mol Cell 45: 171-184, 2012.
5. Qi R, An H, Yu Y, et al: Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63: 8323-8329, 2003.
6. Viatour P, Ehmer U, Saddic LA, et al: Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway. J Exp Med 208: 1963-1976, 2011.
7. Zong Y, Panikkar A, Xu J, et al: Notch signaling controls liver development by regulating biliary differentiation. Development 136: 1727-1739, 2009.
8. Mazzone M, Selfors LM, Albeck J, et al: Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells. Proc Natl Acad Sci USA 107: 5012-5017, 2010.
9. D'Souza B, Meloty-Kapella L and Weinmaster G: Canonical and non-canonical Notch ligands. Curr Top Dev Biol 92: 73-129, 2010.
10. Artavanis-Tsakonas S and Muskavitch MA: Notch: The past, the present, and the future. Curr Top Dev Biol 92: 1-29, 2010.
11. Kovall RA and Blacklow SC: Mechanistic insights into Notch receptor signaling from structural and biochemical studies. Curr Top Dev Biol 92: 31-71, 2010.
12. Le Bras S, Loyer N and Le Borgne R: The multiple facets of ubiquitination in the regulation of notch signaling pathway. Traffic 12: 149-161, 2011.
13. Fortini ME: Notch signaling: The core pathway and its posttranslational regulation. Dev Cell 16: 633-647, 2009.
14. De la Pompa JL and Epstein JA: Coordinating tissue interactions: Notch signaling in cardiac development and disease. Dev Cell 22: 244-254, 2012.
15. Wang Z, Li Y, Kong D and Sarkar FH: The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr Drug Targets 11: 745-751, 2010.
16. Leong KG, Niessen K, Kulic I, et al: Jagged1-mediated Notch activation induces epithelial-Yo-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204: 2935-2948, 2007.
17. Santagata S, Demichelis F, Riva A, et al: JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64: 6854-6857, 2004.
18. Villanueva A, Alsinet C, Yanger K, et al: Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice. Gastroenterology 143: 1660-1669.e7, 2012.
19. Chen RX, Xia YH, Xue TC, Zhang H and Ye SL: Downregulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Oncol Rep 25: 803-808, 2011.
20. Xue TC, Han D, Chen RX, et al: High expression of CXCR7 combined with alpha fetoprotein in hepatocellular carcinoma correlates with extra-hepatic metastasis to lung after hepatectomy. Asian Pac J Cancer Prev 12: 657-663, 2011.
21. Simon R, Mirlacher M and Sauter G: Immunohistochemical analysis of tissue microarrays. Methods Mol Biol 664: 113-126, 2010.
22. Wang M, Xue L, Cao Q, et al: Expression of Notch1, Jagged1 and beta-catenin and their clinicopathological significance in hepatocellular carcinoma. Neoplasma 56: 533-541, 2009.
23. Lim SO, Kim HS, Quan X, et al: Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol 9: 83, 2011.
24. Andersen P, Uosaki H, Shenje LT and Kwon C: Non-canonical Notch signaling: Emerging role and mechanism. Trends Cell Biol 22: 257-265, 2012.
25. Wang XQ, Zhang W, Lui EL, et al: Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma. Int J Cancer 131: E163-E172, 2012.
26. Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and Dou KF: Downregulation of the Notch signaling pathway inhibits hepatocellular carcinoma cell invasion by inactivation of matrix metalloproteinase-2 and -9 and vascular endothelial growth factor. Oncol Rep 28: 874-882, 2012.
27. Ye QH, Qin LX, Forgues M, et al: Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9: 416-423, 2003.
28. Dong QZ, Zhang XF, Zhao Y, et al: Osteopontin promoter polymorphisms at locus -443 significantly affect the metastasis and prognosis of human hepatocellular carcinoma. Hepatology 57: 1024-1034, 2012.